WallStreetZenWallStreetZen

NYSE: ANVS
Annovis Bio Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ANVS

Based on 1 analyst offering 12 month price targets for Annovis Bio Inc

Min Forecast
$17.00+690.7%
Avg Forecast
$17.00+690.7%
Max Forecast
$17.00+690.7%

Should I buy or sell ANVS stock?

Based on 1 analyst offering ratings for Annovis Bio Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ANVS's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates ANVS as a "Strong Sell". Stocks with a Zen Rating of Strong Sell have had an average return of -8.02% per year. Learn More

Be the first to know when Wall Street analysts revise their ANVS stock forecasts and price targets.

ANVS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-09-30

1 of 1

Forecast return on equity

Is ANVS forecast to generate an efficient return?

Company
-66.94%
Industry
62.84%
Market
179.06%
ANVS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ANVS forecast to generate an efficient return on assets?

Company
-53.5%
Industry
31.64%
ANVS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ANVS earnings per share forecast

What is ANVS's earnings per share in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
-$1.43
Avg 2 year Forecast
-$1.28
Avg 3 year Forecast
-$2.11

ANVS revenue forecast

What is ANVS's revenue in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$0.0
Avg 3 year Forecast
$51.5M

ANVS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ANVS$2.15$17.00+690.70%Strong Buy
FRMM$2.85N/AN/A
IBO$0.57N/AN/A
OKYO$1.58$6.00+279.75%Strong Buy
EXOZ$7.23N/AN/A
View Top Biotech Stocks

Annovis Bio Stock Forecast FAQ

Is Annovis Bio Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NYSE: ANVS) stock is to Strong Buy ANVS stock.

Out of 1 analyst, 1 (100%) are recommending ANVS as a Strong Buy, 0 (0%) are recommending ANVS as a Buy, 0 (0%) are recommending ANVS as a Hold, 0 (0%) are recommending ANVS as a Sell, and 0 (0%) are recommending ANVS as a Strong Sell.

If you're new to stock investing, here's how to buy Annovis Bio stock.

What is ANVS's earnings growth forecast for 2026-2028?

(NYSE: ANVS) Annovis Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.89%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 35.94%.

Annovis Bio's earnings in 2026 is -$28,854,197.On average, 6 Wall Street analysts forecast ANVS's earnings for 2026 to be -$40,417,590, with the lowest ANVS earnings forecast at -$41,960,117, and the highest ANVS earnings forecast at -$33,941,249. On average, 4 Wall Street analysts forecast ANVS's earnings for 2027 to be -$36,152,959, with the lowest ANVS earnings forecast at -$38,347,656, and the highest ANVS earnings forecast at -$33,345,788.

In 2028, ANVS is forecast to generate -$59,869,300 in earnings, with the lowest earnings forecast at -$57,521,484 and the highest earnings forecast at -$61,630,162.

What is ANVS's revenue growth forecast for 2026-2028?

(NYSE: ANVS) Annovis Bio's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.08%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.19%.

Annovis Bio's revenue in 2026 is $0.On average, 6 Wall Street analysts forecast ANVS's revenue for 2026 to be $0, with the lowest ANVS revenue forecast at $0, and the highest ANVS revenue forecast at $0. On average, 4 Wall Street analysts forecast ANVS's revenue for 2027 to be $0, with the lowest ANVS revenue forecast at $0, and the highest ANVS revenue forecast at $0.

In 2028, ANVS is forecast to generate $1,461,458,559 in revenue, with the lowest revenue forecast at $474,099,981 and the highest revenue forecast at $2,500,934,108.

What is ANVS's forecast return on assets (ROA) for 2026-2029?

(NYSE: ANVS) forecast ROA is -53.5%, which is lower than the forecast US Biotechnology industry average of 31.64%.

What is ANVS's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ANVS price target, the average ANVS price target is $17.00, with the highest ANVS stock price forecast at $17.00 and the lowest ANVS stock price forecast at $17.00.

The Wall Street analyst predicted that Annovis Bio's share price could reach $17.00 by Sep 30, 2026. The average Annovis Bio stock price prediction forecasts a potential upside of 690.7% from the current ANVS share price of $2.15.

What is ANVS's Earnings Per Share (EPS) forecast for 2026-2028?

(NYSE: ANVS) Annovis Bio's current Earnings Per Share (EPS) is -$1.40. On average, analysts forecast that ANVS's EPS will be -$1.43 for 2026, with the lowest EPS forecast at -$1.48, and the highest EPS forecast at -$1.20. On average, analysts forecast that ANVS's EPS will be -$1.28 for 2027, with the lowest EPS forecast at -$1.35, and the highest EPS forecast at -$1.18. In 2028, ANVS's EPS is forecast to hit -$2.11 (min: -$2.03, max: -$2.17).

What is ANVS's forecast return on equity (ROE) for 2026-2029?

(NYSE: ANVS) forecast ROE is -66.94%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.